Carbone, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 951
AS - Asia 931
EU - Europa 744
SA - Sud America 160
AF - Africa 21
OC - Oceania 1
Totale 2.808
Nazione #
US - Stati Uniti d'America 904
SG - Singapore 378
IT - Italia 305
CN - Cina 187
BR - Brasile 135
VN - Vietnam 101
SE - Svezia 86
DE - Germania 77
FR - Francia 72
IN - India 55
HK - Hong Kong 42
NL - Olanda 35
GB - Regno Unito 32
FI - Finlandia 31
JP - Giappone 30
CA - Canada 28
BD - Bangladesh 26
IE - Irlanda 26
ID - Indonesia 24
RU - Federazione Russa 17
PL - Polonia 15
KR - Corea 12
TR - Turchia 12
AT - Austria 10
IQ - Iraq 10
MX - Messico 10
AR - Argentina 9
UA - Ucraina 8
BE - Belgio 7
CH - Svizzera 6
EC - Ecuador 6
KE - Kenya 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
IR - Iran 5
CO - Colombia 4
CI - Costa d'Avorio 3
ES - Italia 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
IL - Israele 2
LB - Libano 2
PR - Porto Rico 2
ZA - Sudafrica 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MK - Macedonia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.808
Città #
Singapore 227
Ashburn 132
San Jose 111
Rome 90
Chandler 72
Milan 43
Beijing 41
Hong Kong 40
Hefei 35
Ho Chi Minh City 32
Hyderabad 31
Council Bluffs 30
Hanoi 28
Los Angeles 26
Tokyo 26
Boardman 23
Dublin 22
Lauterbourg 22
Jakarta 20
Munich 20
Dallas 19
St Louis 19
The Dalles 19
New York 18
Chicago 17
Frankfurt am Main 16
Helsinki 14
Warsaw 12
Seoul 11
Boston 10
Buffalo 10
Cattolica 9
Düsseldorf 9
Montreal 9
Palermo 9
Princeton 9
Santa Clara 9
Stockholm 9
Atlanta 8
Fairfield 8
Kent 8
Lappeenranta 8
Marseille 8
Nuremberg 8
Toronto 8
Dhaka 7
Houston 7
Orem 7
São Paulo 7
Turku 7
Wilmington 7
Brussels 6
London 6
Mexico City 6
Phoenix 6
Vienna 6
Washington 6
Amsterdam 5
Bremen 5
Brooklyn 5
Moscow 5
Nairobi 5
Naples 5
San Mateo 5
Seattle 5
Tashkent 5
Turin 5
Verona 5
Ankara 4
Ann Arbor 4
Bexley 4
Busto Arsizio 4
Cambridge 4
Campinas 4
Chennai 4
Curitiba 4
Da Nang 4
Florence 4
Genoa 4
Memphis 4
Newark 4
North Bergen 4
Paris 4
Ryazan 4
Abidjan 3
Amman 3
Augusta 3
Bangkok 3
Bari 3
Belo Horizonte 3
Charlotte 3
Chions 3
Denver 3
Falkenstein 3
Haiphong 3
Hangzhou 3
Istanbul 3
Jeddah 3
Mumbai 3
Norwalk 3
Totale 1.600
Nome #
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 292
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 195
Gut microbiome, big data and machine learning to promote precision medicine for cancer 191
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 183
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 154
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 135
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 132
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 130
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 129
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 119
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 113
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 109
Endoscopic ultrasound-guided therapies for pancreatic solid tumors: An overview 103
Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response 103
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy 95
Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study 95
Molecular alterations in basal cell carcinoma subtypes 91
Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers 90
Inflammatory profile in mitochondrial diseases: A cohort study 90
Inflammatory profile in mitochondrial diseases: A cohort study 77
Revising PTEN in the era of immunotherapy: New perspectives for an old story 76
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 69
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 59
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to Kras G12D Inhibition in Pancreatic Cancer 18
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 5
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 4
Totale 2.857
Categoria #
all - tutte 11.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022118 0 13 3 12 10 5 6 12 6 4 22 25
2022/2023247 31 34 15 37 7 28 14 16 30 5 12 18
2023/2024246 8 29 13 13 12 19 35 11 7 27 19 53
2024/2025622 13 12 50 30 26 28 39 26 73 85 145 95
2025/20261.588 167 71 100 160 255 88 270 81 130 97 120 49
Totale 2.857